9,637
Total Claims
$1.8M
Drug Cost
1,016
Beneficiaries
$1,787
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
+17%
Cost per patient vs peers
$1,787 vs $1,524 avg
+14%
Brand preference vs peers
15.6% vs 13.7% avg
Brand vs Generic
84% generic
Brand: 1,505 claims · $1.6M
Generic: 8,132 claims · $187K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 557 | $627K |
| Rivaroxaban | 233 | $299K |
| Evolocumab | 147 | $166K |
| Ticagrelor | 203 | $166K |
| Sacubitril/Valsartan | 98 | $139K |
| Empagliflozin | 84 | $98K |
| Alirocumab | 100 | $92K |
| Ezetimibe | 491 | $27K |
| Rosuvastatin Calcium | 1,071 | $23K |
| Atorvastatin Calcium | 1,478 | $23K |
| Dapagliflozin Propanediol | 12 | $19K |
| Icosapent Ethyl | 27 | $15K |
| Metoprolol Succinate | 460 | $14K |
| Carvedilol | 451 | $6,568 |
| Potassium Chloride | 210 | $6,072 |
Prescribing Profile
44
Unique Drugs
$1.2M
Patient Profile
76
Avg Age
42%
Female
1.38
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data